Opzelura shows strong results in phase 3b trial for moderate atopic dermatitis - PharmaTimes
Opzelura Shows Strong Results in Phase 3b Trial for Moderate Atopic Dermatitis New data support European filing for nonsteroidal topical treatment. Incyte has announced promising ne…